Convergence Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,095
| Closed | -$441K | – | 311 |
|
|
2024
Q4 | $441K | Buy |
1,095
+573
| +110% | +$231K | 0.1% | 192 |
|
|
2024
Q3 | $243K | Sell |
522
-33
| -6% | -$15.3K | 0.07% | 217 |
|
|
2024
Q2 | $260K | Sell |
555
-751
| -58% | -$352K | 0.08% | 222 |
|
|
2024
Q1 | $546K | Buy |
1,306
+148
| +13% | +$61.9K | 0.21% | 124 |
|
|
2023
Q4 | $471K | Sell |
1,158
-163
| -12% | -$66.3K | 0.25% | 96 |
|
|
2023
Q3 | $459K | Buy |
1,321
+533
| +68% | +$185K | 0.27% | 93 |
|
|
2023
Q2 | $277K | Sell |
788
-709
| -47% | -$249K | 0.16% | 129 |
|
|
2023
Q1 | $472K | Sell |
1,497
-266
| -15% | -$83.9K | 0.28% | 97 |
|
|
2022
Q4 | $509K | Sell |
1,763
-5
| -0.3% | -$1.44K | 0.3% | 91 |
|
|
2022
Q3 | $512K | Buy |
1,768
+451
| +34% | +$131K | 0.33% | 87 |
|
|
2022
Q2 | $371K | Buy |
1,317
+120
| +10% | +$33.8K | 0.22% | 106 |
|
|
2022
Q1 | $312K | Buy |
+1,197
| New | +$312K | 0.16% | 132 |
|
|
2021
Q1 | – | Sell |
-1,379
| Closed | -$326K | – | 278 |
|
|
2020
Q4 | $326K | Buy |
+1,379
| New | +$326K | 0.16% | 129 |
|
|
2018
Q2 | – | Sell |
-14,920
| Closed | -$2.43M | – | 895 |
|
|
2018
Q1 | $2.43M | Buy |
14,920
+1,527
| +11% | +$249K | 0.32% | 119 |
|
|
2017
Q4 | $2.01M | Sell |
13,393
-563
| -4% | -$84.4K | 0.27% | 129 |
|
|
2017
Q3 | $2.12M | Buy |
13,956
+2,857
| +26% | +$434K | 0.3% | 127 |
|
|
2017
Q2 | $1.43M | Buy |
+11,099
| New | +$1.43M | 0.21% | 189 |
|